These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 544293)

  • 1. A test method for the absence of thrombogenicity in factor IX complex.
    Miura Y; Abe T; Kazama M; Yasuda J
    Dev Biol Stand; 1979; 44():189-97. PubMed ID: 544293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C; Menart C; Attali O; Petit PY; Lienhart A; Dechavanne M; Ingerslev J
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser nephelometer evaluation of factor IX.
    Ruzza G; Lazzaro AR; Viero ML; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report.
    De Pietri L; Masetti M; Montalti R; Begliomini B; Reggiani A; Barbieri E; Biagioni E; Marietta M; Romano A; Pasetto A; Gerunda GE
    Transplant Proc; 2008; 40(6):2077-9. PubMed ID: 18675136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test method for the absence of active clotting factors in dried human blood coagulation factor IX complex.
    Miura Y
    Jpn J Med Sci Biol; 1978; 31(5-6):371-6. PubMed ID: 752738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of factor IX: standards for "purified" factor IX concentrates.
    Lamb MA; Fricke WA; Rastogi SC
    Thromb Haemost; 1991 Nov; 66(5):548-51. PubMed ID: 1803618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially thrombogenic materials in factor IX concentrates.
    Kingdon HS; Lundblad RL; Veltkamp JJ; Aronson DL
    Thromb Diath Haemorrh; 1975 Jun; 33(3):617-31. PubMed ID: 1154317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on blood clotting factors in man after massive liver resection.
    Niléhn JE; Nilsson IM; Aronsen KF; Ericsson B
    Acta Chir Scand; 1967; 133(3):189-95. PubMed ID: 6030166
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombogenicity associated with factor IX complex concentrates.
    Lusher JM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of adrenaline infusions on blood coagulation in normal and haemophilia B dogs.
    Ozge AH; Rowsell HC; Downie HG; Mustard JF
    Thromb Diath Haemorrh; 1966 May; 15(3):349-64. PubMed ID: 5989023
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
    Rodeghiero F; Castronovo S; Dini E
    Thromb Haemost; 1982 Dec; 48(3):339-40. PubMed ID: 6984544
    [No Abstract]   [Full Text] [Related]  

  • 18. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
    Hedner U; Nilsson IM; Bergentz SE
    Thromb Haemost; 1976 Apr; 35(2):386-95. PubMed ID: 989639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
    Ruiz-Sáez A; Hong A; Arguello A; Echenagucia M; Boadas A; Fabbrizzi F; Minichilli F; Bosch NB
    Haemophilia; 2005 Nov; 11(6):583-8. PubMed ID: 16236107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.